PUBLISHED DATE : Jun 2022 | Pages : 342
Fill out your details & get your free sample
The Global In Vitro Diagnostics (IVD) Raw Materials Market Size, Share, & Trends Analysis Report by
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027.
342 Pages
164 Tables
139 Charts
5 Regions
18 Countries
39 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 34.25 BILLION (2027) |
| CAGR (REVENUE) | 5.86% (2022-2027) |
| BASE YEAR | 2021 |
| FORECAST PERIOD | 2022-2027 |
| MARKET SEGMENTS | Product: Antibody & Antigen, Enzymes, Proteins, Biological Buffers, and Others, Technology: Clinical Chemistry, Immunochemistry, Molecular Diagnostics, and Others, End-User: Pharma & Biotech Companies, Diagnostic Laboratories, and Others, Geography: Europe, North America, APAC, Latin America, and Middle East & Africa |
| GEOGRAPHICAL ANALYSIS | Europe, North America, APAC, Latin America, and Middle East & Africa |
| COUNTRIES COVERED | Germany, Italy, France, UK, Spain, US, Canada, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, and South Africa |
IVD raw materials market size was valued at USD 24.34 billion in 2021 and is expected to reach USD 34.25 billion by 2027, growing at a CAGR of 5.86% during the forecast period.
With the rise in chronic conditions and patient populations, the demand for diagnostics and laboratory tests increases. The growing demand for antigen and antibody-based tests that increased during COVID-19 led to its major market share. It is expected to have the highest incremental growth of USD 3.92 billion and absolute growth of 44.41% during the forecast period.
The Europe region is one of the matured markets for in-vitro diagnostic; the large laboratory instruments are highly automated compared to most point-of-care testing devices. Automation has increased the speed and ease of using the devices the workforce is thoroughly trained and adopted. Furthermore, the global IVD raw materials market is expected to witness an incremental growth of USD 9.91 billion and absolute growth of 40.73% by 2027.
Rapid tests developed through clinical chemistry provides test results immediately. Manufacturers offer many IVD raw materials applicable to clinical chemistry methods. The global IVD raw materials market by clinical chemistry is expected to reach USD 12.14 billion by 2027. Furthermore, private laboratories have expanded their footprints in recent years, especially in developing countries, which has stimulated market growth. Moreover, the demand for standalone reference laboratories is gradually rising due to the prevalence of epidemic and pandemic conditions across the globe. The global IVD raw materials market by diagnostic laboratories will grow at a CAGR of over 6% during 2022-2027.
Major manufacturers of IVD raw materials are focusing on their proprietary processing techniques that satisfy the raw material requirements of the IVD industry and provide IVD raw materials made to their own with the off-the-shelf specification. Vendors are constantly investing resources in R&D projects based on market trends and the demand for general health management. Key players are also engaged in strategic acquisitions as part of their inorganic growth strategy to enhance sales and profit margins. Strategic M&As continue to be an essential competitive strategy for key players to expand product offerings, access new technology, or increase market share. Vendors also focus on developing and commercializing innovative analyzers, COVID-19 PCR rapid test kits, and consumables to remain competitive and gain a significant presence in the IVD raw materials market.
In 2021, Europe dominated the global IVD raw materials market compared to other regions. This region is a mature market with developed diagnostic infrastructure available in most countries. The demand for advanced molecular diagnostics in the European countries has gone high owing to the presence of advanced infrastructure in healthcare diagnosis. Point of care diagnostics is the latest trend in the European market. The Europe IVD raw materials market is expected to reach USD 11.80 billion by 2027.
Frequently Asked Questions
HOW BIG IS THE IVD RAW MATERIALS MARKET?
The IVD raw materials market to reach USD 34.25 billion by 2027.
WHAT ARE THE GROWTH ENABLERS IN THE IVD RAW MATERIALS MARKET?
Increasing prevalence of infectious & chronic diseases, growing awareness for early diagnosis and disease prevention, and surge in demand For IVD testing & devices are the growth enablers in the market.
WHO ARE THE KEY PLAYERS IN THE IVD RAW MATERIALS MARKET
Key players include Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KGaA, F. Hoffmann-La Roche, and Thermo Fisher Scientific.
WHICH REGION HOLDS THE LARGEST SHARE IN THE IVD RAW MATERIALS MARKET?
Europe holds the largest share in the IVD raw materials market.
WHAT ARE THE KEY TRENDS IN THE IVD RAW MATERIALS MARKET?
Rising demand for point of care PCR diagnostics, personalized medicine, and molecular diagnostics are the key trends in the IVD raw materials market.
The IVD raw materials market by revenue is expected to grow at a CAGR of 5.86% during 2022-2027.
The following factors are likely to contribute to the growth of the IVD raw materials market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the IVD raw materials market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY TECHNOLOGY
4.3.3 MARKET SEGMENTATION BY END USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 MARKET OPPORTUNITIES & TRENDS
8.1 GROWING DEMAND FOR POINT-OF-CARE PCR DIAGNOSTICS
8.2 SURGE IN PREFERENCE FOR PERSONALIZED MEDICINE
8.3 RISE IN DEMAND FOR MOLECULAR DIAGNOSTICS
8.4 ADVANCED TECHNOLOGIES IN IVD PRODUCTS
9 MARKET GROWTH ENABLERS
9.1 INCREASING PREVALENCE OF INFECTIOUS & CHRONIC DISEASES
9.2 GROWING AWARENESS OF EARLY DIAGNOSIS AND DISEASE PREVENTION
9.3 HIGH DEMAND FOR IVD TESTS & DEVICES
9.4 RISE IN AVAILABILITY OF ADVANCED HOME CARE KITS FOR CANCER DIAGNOSTICS
10 MARKET RESTRAINTS
10.1 LOT-TO-LOT VARIATIONS IN IVD REAGENTS
10.2 STRINGENT REGULATIONS FOR PRODUCT APPROVALS
10.3 LOWER PENETRATION OF IVD DEVICES IN LMICS
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 DEMAND FOR IVD RAW MATERIALS DURING COVID-19
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 PRODUCT
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 ANTIBODIES & ANTIGENS
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 ANTIBODIES & ANTIGENS: GEOGRAPHY SEGMENTATION
12.4 ENZYMES
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 ENZYMES: GEOGRAPHY SEGMENTATION
12.5 PROTEINS
12.5.1 MARKET OVERVIEW
12.5.2 MARKET SIZE & FORECAST
12.5.3 PROTEINS: GEOGRAPHY SEGMENTATION
12.6 BIOLOGICAL BUFFERS
12.6.1 MARKET OVERVIEW
12.6.2 MARKET SIZE & FORECAST
12.6.3 BIOLOGICAL BUFFERS: GEOGRAPHY SEGMENTATION
12.7 OTHERS
12.7.1 MARKET OVERVIEW
12.7.2 MARKET SIZE & FORECAST
12.7.3 OTHERS: GEOGRAPHY SEGMENTATION
13 TECHNOLOGY
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CLINICAL CHEMISTRY
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 CLINICAL CHEMISTRY: GEOGRAPHY SEGMENTATION
13.4 IMMUNOCHEMISTRY
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 IMMUNOCHEMISTRY: GEOGRAPHY SEGMENTATION
13.5 MOLECULAR DIAGNOSTICS
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MOLECULAR DIAGNOSTICS: GEOGRAPHY SEGMENTATION
13.6 OTHERS
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 OTHERS: GEOGRAPHY SEGMENTATION
14 END USER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 PHARMA/BIOTECH & MEDTECH COMPANIES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 PHARMA/BIOTECH & MEDTECH COMPANIES: GEOGRAPHY SEGMENTATION
14.4 DIAGNOSTIC LABORATORIES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 DIAGNOSTIC LABORATORIES: GEOGRAPHY SEGMENTATION
14.5 OTHERS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 OTHERS: GEOGRAPHY SEGMENTATION
15 GEOGRAPHY
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW
16 EUROPE
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.2.1 EUROPE: PRODUCT
16.2.2 EUROPE: TECHNOLOGY
16.2.3 EUROPE: END USER
16.3 KEY COUNTRIES
16.3.1 GERMANY: MARKET SIZE & FORECAST
16.3.2 ITALY: MARKET SIZE & FORECAST
16.3.3 FRANCE: MARKET SIZE & FORECAST
16.3.4 UK: MARKET SIZE & FORECAST
16.3.5 SPAIN: MARKET SIZE & FORECAST
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.2.1 NORTH AMERICA: PRODUCT
17.2.2 NORTH AMERICA: TECHNOLOGY
17.2.3 NORTH AMERICA: END USER
17.3 KEY COUNTRIES
17.3.1 US: MARKET SIZE & FORECAST
17.3.2 CANADA: MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 APAC: PRODUCT
18.2.2 APAC: TECHNOLOGY
18.2.3 APAC: END USER
18.3 KEY COUNTRIES
18.3.1 CHINA: MARKET SIZE & FORECAST
18.3.2 JAPAN: MARKET SIZE & FORECAST
18.3.3 INDIA: MARKET SIZE & FORECAST
18.3.4 AUSTRALIA: MARKET SIZE & FORECAST
18.3.5 SOUTH KOREA: MARKET SIZE & FORECAST
19 LATIN AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 LATIN AMERICA: PRODUCT
19.2.2 LATIN AMERICA: TECHNOLOGY
19.2.3 LATIN AMERICA: END USER
19.3 KEY COUNTRIES
19.3.1 BRAZIL: MARKET SIZE & FORECAST
19.3.2 MEXICO: MARKET SIZE & FORECAST
19.3.3 ARGENTINA: MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 MIDDLE EAST & AFRICA: PRODUCT
20.2.2 MIDDLE EAST & AFRICA: TECHNOLOGY
20.2.3 MIDDLE EAST & AFRICA: END USER
20.3 KEY COUNTRIES
20.3.1 TURKEY: MARKET SIZE & FORECAST
20.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
20.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
21.2 MARKET SHARE ANALYSIS
21.2.1 AALTO BIO REAGENTS
21.2.2 FAPON BIOTECH
21.2.3 FUJIREBIO
21.2.4 MERCK KGAA
21.2.5 F. HOFFMANN-LA ROCHE
21.2.6 THERMO FISHER SCIENTIFIC
22 KEY COMPANY PROFILES
22.1 AALTO BIO REAGENTS
22.1.1 BUSINESS OVERVIEW
22.1.2 AALTO BIO REAGENTS IN IVD RAW MATERIALS MARKET
22.1.3 PRODUCT OFFERINGS
22.1.4 KEY STRATEGIES
22.1.5 KEY STRENGTHS
22.1.6 KEY OPPORTUNITIES
22.2 FAPON BIOTECH
22.2.1 BUSINESS OVERVIEW
22.2.2 FAPON BIOTECH IN IVD RAW MATERIALS MARKET
22.2.3 PRODUCT OFFERINGS
22.2.4 KEY STRATEGIES
22.2.5 KEY STRENGTHS
22.2.6 KEY OPPORTUNITIES
22.3 FUJIREBIO
22.3.1 BUSINESS OVERVIEW
22.3.2 FUJIREBIO IN IVD RAW MATERIALS MARKET
22.3.3 PRODUCT OFFERINGS
22.3.4 KEY STRATEGIES
22.3.5 KEY STRENGTHS
22.3.6 KEY OPPORTUNITIES
22.4 MERCK KGAA
22.4.1 BUSINESS OVERVIEW
22.4.2 MERCK KGAA IN IVD RAW MATERIALS MARKET
22.4.3 PRODUCT OFFERINGS
22.4.4 KEY STRATEGIES
22.4.5 KEY STRENGTHS
22.4.6 KEY OPPORTUNITIES
22.5 F. HOFFMANN-LA ROCHE
22.5.1 BUSINESS OVERVIEW
22.5.2 F. HOFFMANN-LA ROCHE IN IVD RAW MATERIALS MARKET
22.5.3 PRODUCT OFFERINGS
22.5.4 KEY STRATEGIES
22.5.5 KEY STRENGTHS
22.5.6 KEY OPPORTUNITIES
22.6 THERMO FISHER SCIENTIFIC
22.6.1 BUSINESS OVERVIEW
22.6.2 THERMO FISHER SCIENTIFIC IN IVD RAW MATERIALS MARKET
22.6.3 PRODUCT OFFERINGS
22.6.4 KEY STRATEGIES
22.6.5 KEY STRENGTHS
22.6.6 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
23.1 ABCLONAL
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.2 BBI SOLUTIONS
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.3 BEIJING DIAGREAT BIOTECHNOLOGY
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.4 BIOFOOTPRINTS HEALTHCARE
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.5 BIOPORTO
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.6 CREATIVE DIAGNOSTICS
23.6.1 BUSINESS OVERVIEW
23.6.2 PRODUCT OFFERINGS
23.7 CUSABIO TECHNOLOGY
23.7.1 BUSINESS OVERVIEW
23.7.2 PRODUCT OFFERINGS
23.8 EUPROTEIN
23.8.1 BUSINESS OVERVIEW
23.8.2 PRODUCT OFFERINGS
23.9 EXIMIO BIOTEC
23.9.1 BUSINESS OVERVIEW
23.9.2 PRODUCT OFFERINGS
23.10 GENSCRIPT PROBIO
23.10.1 BUSINESS OVERVIEW
23.10.2 PRODUCT OFFERINGS
23.11 GETEIN BIOTECH
23.11.1 BUSINESS OVERVIEW
23.11.2 PRODUCT OFFERINGS
23.12 GLENTHAM LIFE SCIENCES
23.12.1 BUSINESS OVERVIEW
23.12.2 PRODUCT OFFERINGS
23.13 HYTEST
23.13.1 BUSINESS OVERVIEW
23.13.2 PRODUCT OFFERINGS
23.14 IMMUNODIAGNOSTICS
23.14.1 BUSINESS OVERVIEW
23.14.2 PRODUCT OFFERINGS
23.15 LGC
23.15.1 BUSINESS OVERVIEW
23.15.2 PRODUCT OFFERINGS
23.16 MEDIX BIOCHEMICA
23.16.1 BUSINESS OVERVIEW
23.16.2 PRODUCT OFFERINGS
23.17 MERIDIAN BIOSCIENCE
23.17.1 BUSINESS OVERVIEW
23.17.2 PRODUCT OFFERINGS
23.18 MORE DIAGNOSTICS
23.18.1 BUSINESS OVERVIEW
23.18.2 PRODUCT OFFERINGS
23.19 MP BIOMEDICALS
23.19.1 BUSINESS OVERVIEW
23.19.2 PRODUCT OFFERINGS
23.20 NANJING OKAY BIOTECHNOLOGY
23.20.1 BUSINESS OVERVIEW
23.20.2 PRODUCT OFFERINGS
23.21 NITTO BOSEKI
23.21.1 BUSINESS OVERVIEW
23.21.2 PRODUCT OFFERINGS
23.22 OYC EUROPE
23.22.1 BUSINESS OVERVIEW
23.22.2 PRODUCT OFFERINGS
23.23 PRAHAS HEALTHCARE
23.23.1 BUSINESS OVERVIEW
23.23.2 PRODUCT OFFERINGS
23.24 PROMEGA
23.24.1 BUSINESS OVERVIEW
23.24.2 PRODUCT OFFERINGS
23.25 REAGENT
23.25.1 BUSINESS OVERVIEW
23.25.2 PRODUCT OFFERINGS
23.26 ROCKLAND IMMUNOCHEMICALS
23.26.1 BUSINESS OVERVIEW
23.26.2 PRODUCT OFFERINGS
23.27 SEKISUI DIAGNOSTICS
23.27.1 BUSINESS OVERVIEW
23.27.2 PRODUCT OFFERINGS
23.28 SERION IMMUNOLOGICS
23.28.1 BUSINESS OVERVIEW
23.28.2 PRODUCT OFFERINGS
23.29 SIGNALWAY ANTIBODY
23.29.1 BUSINESS OVERVIEW
23.29.2 PRODUCT OFFERINGS
23.30 SUZHOU YACOO SCIENCE
23.30.1 BUSINESS OVERVIEW
23.30.2 PRODUCT OFFERINGS
23.31 TRINA BIOREACTIVES
23.31.1 BUSINESS OVERVIEW
23.31.2 PRODUCT OFFERINGS
23.32 WATSON INTERNATIONAL
23.32.1 BUSINESS OVERVIEW
23.32.2 PRODUCT OFFERINGS
23.33 WUHAN HUAMEI BIOTECH
23.33.1 BUSINESS OVERVIEW
23.33.2 PRODUCT OFFERINGS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 MARKET BY PRODUCT
25.1.1 EUROPE: PRODUCT SEGMENTATION
25.1.2 NORTH AMERICA: PRODUCT SEGMENTATION
25.1.3 APAC: PRODUCT SEGMENTATION
25.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
25.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
25.2 MARKET BY TECHNOLOGY
25.2.1 EUROPE: TECHNOLOGY SEGMENTATION
25.2.2 NORTH AMERICA: TECHNOLOGY SEGMENTATION
25.2.3 APAC: TECHNOLOGY SEGMENTATION
25.2.4 LATIN AMERICA: TECHNOLOGY SEGMENTATION
25.2.5 MIDDLE EAST & AFRICA: TECHNOLOGY SEGMENTATION
25.3 MARKET BY END USER
25.3.1 EUROPE: END USER SEGMENTATION
25.3.2 NORTH AMERICA: END-USER SEGMENTATION
25.3.3 APAC: END-USER SEGMENTATION
25.3.4 LATIN AMERICA: END-USER SEGMENTATION
25.3.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
25.4 MARKET BY GEOGRAPHY
25.4.1 ANTIBODIES & ANTIGENS: GEOGRAPHY SEGMENTATION
25.4.2 ENZYMES: GEOGRAPHY SEGMENTATION
25.4.3 PROTEINS: GEOGRAPHY SEGMENTATION
25.4.4 BIOLOGICAL BUFFERS: GEOGRAPHY SEGMENTATION
25.4.5 OTHER PRODUCTS: GEOGRAPHY SEGMENTATION
25.4.6 CLINICAL CHEMISTRY: GEOGRAPHY SEGMENTATION
25.4.7 IMMUNOCHEMISTRY: GEOGRAPHY SEGMENTATION
25.4.8 MOLECULAR DIAGNOSTICS: GEOGRAPHY SEGMENTATION
25.4.9 OTHER TECHNOLOGIES: GEOGRAPHY SEGMENTATION
25.4.10 PHARMA & BIOTECH COMPANIES: GEOGRAPHY SEGMENTATION
25.4.11 DIAGNOSTIC LABORATORIES: GEOGRAPHY SEGMENTATION
25.4.12 OTHER END USERS: GEOGRAPHY SEGMENTATION
26 APPENDIX
26.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL IVD RAW MATERIALS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 IMPACT OF GROWING DEMAND FOR POINT-OF-CARE PCR DIAGNOSTICS
EXHIBIT 4 IMPACT OF SURGE IN PREFERENCE FOR PERSONALIZED MEDICINE
EXHIBIT 5 IMPACT OF RISE IN DEMAND FOR MOLECULAR DIAGNOSTICS
EXHIBIT 6 IMPACT OF ADVANCED TECHNOLOGIES IN IVD PRODUCTS
EXHIBIT 7 IMPACT OF INCREASING PREVALENCE OF INFECTIOUS & CHRONIC DISEASES
EXHIBIT 8 IMPACT OF GROWING AWARENESS OF EARLY DIAGNOSIS AND DISEASE PREVENTION
EXHIBIT 9 MAJOR ADVANTAGES OF EARLY DIAGNOSIS AND DISEASE PREVENTION
EXHIBIT 10 IMPACT OF HIGH DEMAND FOR IVD TESTS & DEVICES
EXHIBIT 11 IMPACT OF RISE IN AVAILABILITY OF ADVANCED HOMECARE KITS FOR CANCER DIAGNOSTICS
EXHIBIT 12 IMPACT OF LOT-TO-LOT VARIATIONS IN IVD REAGENTS
EXHIBIT 13 IMPACT OF STRINGENT REGULATIONS FOR PRODUCT APPROVALS
EXHIBIT 14 IMPACT OF LOWER PENETRATION OF IVD DEVICES IN LMICS
EXHIBIT 15 GLOBAL IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 16 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT
EXHIBIT 17 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY
EXHIBIT 18 GLOBAL IVD RAW MATERIALS MARKET BY END USER
EXHIBIT 19 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY
EXHIBIT 20 WEEKLY MOLECULAR ASSAYS PERFORMED IN US AND EUROPE DURING NOVEMBER 2020 (MILLIONS)
EXHIBIT 21 FIVE FORCES ANALYSIS 2021
EXHIBIT 22 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 23 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT
EXHIBIT 24 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 25 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 26 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 27 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS 2021–2027 ($ BILLION)
EXHIBIT 28 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 29 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 30 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES 2021–2027 ($ BILLION)
EXHIBIT 31 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 32 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 33 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS 2021–2027 ($ BILLION)
EXHIBIT 34 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 35 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021–2027 ($ BILLION)
EXHIBIT 37 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 38 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021–2027 ($ BILLION)
EXHIBIT 40 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 41 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 42 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY
EXHIBIT 43 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY: INCREMENTAL GROWTH
EXHIBIT 44 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY: ABSOLUTE GROWTH
EXHIBIT 45 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021–2027 ($ BILLION)
EXHIBIT 47 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 48 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021–2027 ($ BILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 51 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021–2027 ($ BILLION)
EXHIBIT 53 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 54 GLOBAL IVD RAW MATERIALS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL IVD RAW MATERIALS MARKET BY OTHER TECHNOLOGIES 2021–2027 ($ BILLION)
EXHIBIT 56 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 57 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 58 GLOBAL IVD RAW MATERIALS MARKET BY END USER
EXHIBIT 59 GLOBAL IVD RAW MATERIALS MARKET BY END USER: INCREMENTAL GROWTH
EXHIBIT 60 GLOBAL IVD RAW MATERIALS MARKET BY END USER: ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 ($ BILLION)
EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 64 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 65 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021–2027 ($ BILLION)
EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 67 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 68 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021–2027 ($ BILLION)
EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 70 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 71 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY
EXHIBIT 72 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY: KEY COUNTRIES (2021)
EXHIBIT 73 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 74 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 75 EUROPE IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)
EXHIBIT 76 EUROPE IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 EUROPE IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 78 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 79 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 80 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 81 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 82 GERMANY IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 83 ITALY IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 84 FRANCE IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 85 UK IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 86 SPAIN IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 87 NORTH AMERICA IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)
EXHIBIT 88 NORTH AMERICA IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 89 NORTH AMERICA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 90 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 91 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 92 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 93 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 94 US IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 95 CANADA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 96 APAC IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)
EXHIBIT 97 APAC IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 98 APAC IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 99 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 100 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 101 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 102 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 103 CHINA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 104 JAPAN IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 105 INDIA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 106 AUSTRALIA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 107 SOUTH KOREA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 108 LATIN AMERICA IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)
EXHIBIT 109 LATIN AMERICA IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 110 LATIN AMERICA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 111 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 112 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 113 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 114 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 115 BRAZIL IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 116 MEXICO IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 117 ARGENTINA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 118 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)
EXHIBIT 119 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 120 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 121 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 122 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 123 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 124 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 125 TURKEY IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 126 SAUDI ARABIA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 127 SOUTH AFRICA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)
EXHIBIT 128 MERCK KGAA: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 129 MERCK KGAA: REVENUE BREAKDOWN BY SEGMENT 2018–2020 ($ MILLION)
EXHIBIT 130 MERCK KGAA: R&D EXPENDITURE 2018–2020 ($ MILLION)
EXHIBIT 131 MERCK KGAA: REVENUE BY GEOGRAPHIC REGION 2018–2020 ($ MILLION)
EXHIBIT 132 F. HOFFMANN-LA ROCHE: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 133 F. HOFFMANN-LA ROCHE: REVENUE BREAKDOWN BY DIVISION 2019–2021 ($ MILLION)
EXHIBIT 134 F. HOFFMANN-LA ROCHE: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 135 F. HOFFMANN-LA ROCHE: REVENUE BY GEOGRAPHICAL REGION 2019–2021 ($ MILLION)
EXHIBIT 136 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 137 THERMO FISHER SCIENTIFIC: REVENUE BREAKDOWN BY SEGMENT 2018–2020 ($ MILLION)
EXHIBIT 138 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2018–2020 ($ MILLION)
EXHIBIT 139 THERMO FISHER SCIENTIFIC: REVENUE BY GEOGRAPHICAL REGION 2018–2020 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2021
TABLE 3 LIST OF SOME IVD RAW MATERIALS APPLICABLE FOR DIFFERENT FUNCTIONS AND SYSTEMS
TABLE 4 VENDORS OFFERING ANTIBODIES & ANTIGENS AS IVD RAW MATERIALS
TABLE 5 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 6 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS 2021–2027 (%) (GEOGRAPHY)
TABLE 7 VENDORS OFFERING ENZYMES AS IVD RAW MATERIALS
TABLE 8 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 9 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES 2021–2027 (%) (GEOGRAPHY)
TABLE 10 VENDORS OFFERING PROTEINS AS IVD RAW MATERIALS
TABLE 11 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 12 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS 2021–2027 (%) (GEOGRAPHY)
TABLE 13 VENDORS OFFERING BIOLOGICAL BUFFERS AS IVD RAW MATERIALS
TABLE 14 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 15 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021–2027 (%) (GEOGRAPHY)
TABLE 16 VENDORS OFFERING HORMONES AS IVD RAW MATERIALS
TABLE 17 VENDORS OFFERING OTHER IVD RAW MATERIALS
TABLE 18 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 19 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021–2027 (%) (GEOGRAPHY)
TABLE 20 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 21 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021–2027 (%) (GEOGRAPHY)
TABLE 22 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 23 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021–2027 (%) (GEOGRAPHY)
TABLE 24 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 25 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021–2027 (%) (GEOGRAPHY)
TABLE 26 GLOBAL IVD RAW MATERIALS MARKET BY OTHERS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 27 GLOBAL IVD RAW MATERIALS MARKET BY OTHERS 2021–2027 (%) (GEOGRAPHY)
TABLE 28 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 29 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 (%) (GEOGRAPHY)
TABLE 30 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 31 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021–2027 (%) (GEOGRAPHY)
TABLE 32 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 33 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021–2027 (%) (GEOGRAPHY)
TABLE 34 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 35 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 36 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 37 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 38 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 39 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 40 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 41 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 42 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 43 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 44 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 45 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 46 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 47 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 48 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 49 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 50 APAC IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 51 APAC IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 52 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 53 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 54 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 55 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 56 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 57 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 58 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 59 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 60 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 61 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 62 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 63 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 64 AALTO BIO REAGENTS: MAJOR PRODUCT OFFERINGS
TABLE 65 FAPON BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 66 FUJIREBIO: MAJOR PRODUCT OFFERINGS
TABLE 67 MERCK KGAA: MAJOR PRODUCT OFFERINGS
TABLE 68 F. HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
TABLE 69 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 70 ABCLONAL: MAJOR PRODUCT OFFERINGS
TABLE 71 BBI SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 72 BEIJING DIAGREAT BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 73 BIOFOOTPRINTS HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 74 BIOPORTO: MAJOR PRODUCT OFFERINGS
TABLE 75 CREATIVE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 76 CUSABIO TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 77 EUPROTEIN: MAJOR PRODUCT OFFERINGS
TABLE 78 EXIMIO BIOTEC: MAJOR PRODUCT OFFERINGS
TABLE 79 GENSCRIPT PROBIO: MAJOR PRODUCT OFFERINGS
TABLE 80 GETEIN BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 81 GLENTHAM LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 82 HYTEST: MAJOR PRODUCT OFFERINGS
TABLE 83 IMMUNODIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 84 LGC: MAJOR PRODUCT OFFERINGS
TABLE 85 MEDIX BIOCHEMICA: MAJOR PRODUCT OFFERINGS
TABLE 86 MERIDIAN BIOSCIENCE: MAJOR PRODUCT OFFERINGS
TABLE 87 MORE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 88 MP BIOMEDICALS: MAJOR PRODUCT OFFERINGS
TABLE 89 NANJING OKAY BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 90 NITTO BOSEKI: MAJOR PRODUCT OFFERINGS
TABLE 91 OYC EUROPE: MAJOR PRODUCT OFFERINGS
TABLE 92 PRAHAS HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 93 PROMEGA: MAJOR PRODUCT OFFERINGS
TABLE 94 REAGENT: MAJOR PRODUCT OFFERINGS
TABLE 95 ROCKLAND IMMUNOCHEMICALS: MAJOR PRODUCT OFFERINGS
TABLE 96 SEKISUI DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 97 SERION IMMUNOLOGICS: MAJOR PRODUCT OFFERINGS
TABLE 98 SIGNALWAY ANTIBODY: MAJOR PRODUCT OFFERINGS
TABLE 99 SUZHOU YACOO SCIENCE: MAJOR PRODUCT OFFERINGS
TABLE 100 TRINA BIOREACTIVES: MAJOR PRODUCT OFFERINGS
TABLE 101 WATSON INTERNATIONAL: MAJOR PRODUCT OFFERINGS
TABLE 102 WUHAN HUAMEI BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 103 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 104 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 105 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 106 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 107 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 108 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 109 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 110 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 111 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 112 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 113 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 114 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)
TABLE 115 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 116 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 117 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 118 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 119 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 120 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 121 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 122 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 123 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 124 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 125 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 126 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 127 GLOBAL IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 128 GLOBAL IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 129 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 130 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 131 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 132 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 133 APAC IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 134 APAC IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 135 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 136 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 137 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 138 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)
TABLE 139 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 140 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 141 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 142 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS BY GEOGRAPHY 2021–2027 (%)
TABLE 143 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 144 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES BY GEOGRAPHY 2021–2027 (%)
TABLE 145 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 146 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS BY GEOGRAPHY 2021–2027 (%)
TABLE 147 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 148 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021–2027 (%) (GEOGRAPHY)
TABLE 149 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 150 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021–2027 (%) (GEOGRAPHY)
TABLE 151 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 152 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021–2027 (%) (GEOGRAPHY)
TABLE 153 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 154 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021–2027 (%) (GEOGRAPHY)
TABLE 155 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 156 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021–2027 (%) (GEOGRAPHY)
TABLE 157 GLOBAL IVD RAW MATERIALS MARKET BY OTHER TECHNOLOGIES 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 158 GLOBAL IVD RAW MATERIALS MARKET BY OTHER TECHNOLOGIES 2021–2027 (%) (GEOGRAPHY)
TABLE 159 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 160 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 (%) (GEOGRAPHY)
TABLE 161 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 162 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021–2027 (%) (GEOGRAPHY)
TABLE 163 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 164 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021–2027 (%) (GEOGRAPHY)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
